Molecular markers of therapeutic resistance in breast cancer

Human Pathology

Volumn 44, Issue 7, 2013, Pages 1421-1428

  Zhou, Ling ^a   Luo, Yanli ^a   Li, Ke ^a   Tian, Ling ^a   Wang, Min ^a   Li, Chuanyuan ^b   Huang, Qian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b DUKE UNIVERSITY   (United States)

Author keywords

ALDH1; Breast cancer; Caspase 3; Cox 2; Triple negative breast cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; ANTINEOPLASTIC AGENT; CASPASE 3; CYCLOOXYGENASE 2; HISTONE H2AX; KI 67 ANTIGEN; PROTEIN KINASE B;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SIZE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PREDICTIVE VALUE; PROTEIN EXPRESSION; TRIPLE NEGATIVE BREAST CANCER;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; CHINA; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; ISOENZYMES; MIDDLE AGED; NEOPLASM STAGING; RETINAL DEHYDROGENASE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879212686     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.10.027     Document Type: Article

References (26)

1. O. Gluz, C. Liedtke, N. Gottschalk, L. Pusztai, U. Nitz, and N. Harbeck Triple-negative breast cancer - current status and future directions Ann Oncol 20 2009 1913 1927
2. A. Gucalp, and T.A. Traina Triple-negative breast cancer: adjuvant therapeutic options Chemother Res Pract 2011 2011 696208
3. M. Garcia, A. Jemal, and E.M. Ward Global Cancer Facts & Figures 2007 2007 American Cancer Society Atlanta, GA
4. S.K. Pal, B.H. Childs, and M. Pegram Triple negative breast cancer: unmet medical needs Breast Cancer Res Treat 125 2011 627 636
5. C. Downs-Holmes, and P. Silverman Breast cancer: overview & updates Nurse Pract 36 2011 20 26
6. K.R. Kutanzi, O.V. Yurchenko, F.A. Beland, V.F. Checkhun, and I.P. Pogribny MicroRNA-mediated drug resistance in breast cancer Clin Epigenetics 2 2011 171 185
7. A.M. Senderowicz Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms Cancer Chemother Pharmacol 52 2003 S61 S73
8. C. Gong, H. Yao, and Q. Liu Markers of tumor-initiating cells predict chemoresistance in breast cancer PLoS One 5 2010 e15630
9. K. Hashimoto, C. Shimizu, and H. Tsuda Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome Oncology 82 2012 168 174
10. M.C. Zatelli, D. Molè, F. Tagliati, M. Minoia, M.R. Ambrosio, and E. degli Uberti Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB Cell Oncol 31 2009 457 465
11. M.C. Zatelli, A. Luchin, and F. Tagliati Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression Endocr Relat Cancer 14 2007 1029 1038
12. C. Falandry, M. Debled, and T. Bachelot Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study Breast Cancer Res Treat 116 2009 501 508
13. S.C. Linn, H.M. Pinedo, and J. van Ark-Otte Expression of drug resistance proteins in breast cancer, in relation to chemotherapy Int J Cancer 71 1997 787 795
14. C. Knuefermann, Y. Lu, and B. Liu HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells Oncogene 22 2003 3205 3212
15. E. Tokunaga, Y. Kimura, and K. Mashino Activation of PI3K/Akt signaling and hormone resistance in breast cancer Breast Cancer 13 2006 137 144
16. D. Generali, S.B. Fox, and M.P. Brizzi Down-regulation of phosphatidylinositol 3′-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer Clin Cancer Res 14 2008 2673 2680
17. F. Végran, R. Boidot, C. Oudin, J.M. Riedinger, F. Bonnetain, and S. Lizard-Nacol Overexpression of caspase-3s splice variant in locally response to neoadjuvant chemotherapy advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy Clin Cancer Res 12 2006 5794 5800
18. D.L. Weaver Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale Mod Pathol 23 2010 S26 S32
19. Q. Huang, F. Li, and X. Liu Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy Nat Med 17 2011 860 866
20. J. Douville, R. Beaulieu, and D. Balicki ALDH1 as a functional marker of cancer stem and progenitor cells Stem Cells Dev 18 2009 17 25
21. T. Tanei, K. Morimoto, and K. Shimazu Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers Clin Cancer Res 15 2009 4234 4241
22. Y. Luo, Z. Qiu, and L. Tian Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma Hum Pathol 44 2013 69 76
23. S. Das, P.P. Ongusaha, Y.S. Yang, J.M. Park, S.A. Aaronson, and S.W. Lee Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation Cancer Res 66 2006 8123 8130
24. J.A. Glover, C.M. Hughes, M.M. Cantwell, and L.J. Murray A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer Br J Cancer 105 2011 13 17
25. C. Johnson-Holiday, R. Singh, E.L. Johnson, W.E. Grizzle, J.W. Lillard Jr., and S. Singh CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion World J Surg Oncol 9 2011 46
26. J. Fillingham, M.C. Keogh, and N.J. Krogan GammaH2AX and its role in DNA double-strand break repair Biochem Cell Biol 84 2006 568 577